Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective stud...

por Park, H.S., Kang, B., Chon, H.J., Im, H.-S., Lee, C.-K., Kim, I., Kang, M.J., Hwang, J.E., Bae, W.K., Cheon, J., Park, J.O., Hong, J.Y., Kang, J.H., Kim, J.H., Lim, S.H., Kim, J.W., Kim, J.-W., Yoo, C., Choi, H.J.
Publicado 2021